Hyperbaric Oxygen As an Adjuvant to Temozolomide Nanoparticle Inhibits Glioma Growth By Inducing G2/M Phase Arrest
Open Access
- 23 February 2018
- journal article
- research article
- Published by Taylor & Francis in Nanomedicine
- Vol. 13 (8) , 887-898
Abstract
Aim: To study the effects of combinational treatment of hyperbaric oxygen (HBO) and nanotemozolomide in glioma. Materials & methods: Temozolomide (TMZ)-loaded porous silicon nanoparticles (TMZ/PSi NPs) were prepared. In vitro and in vivo evaluations were performed. Results: The cell uptake of TMZ/PSi NPs could be tracked by autofluorescence of porous silicon. The concentration of oxygen in tumor was improved and the antitumor rate was increased to 84.2% in the TMZ/PSi NPs combined with HBO group. The viability of hypoxia-induced glioma C6 cells was decreased and cell cycle was arrested at G2/M phase in response to TMZ/PSi NPs treatment with HBO compared with continuous treatment with hypoxia. Conclusion: The combinational treatment of TMZ/PSi NPs and HBO could be a promising therapeutic strategy for glioma.Keywords
This publication has 37 references indexed in Scilit:
- Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?Nature Reviews Clinical Oncology, 2012
- The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells BehaviorInternational Journal of Molecular Sciences, 2012
- Porous Silicon Nanoparticle Photosensitizers for Singlet Oxygen and Their Phototoxicity against Cancer CellsACS Nano, 2011
- Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptidesNature Medicine, 2010
- Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)Pharmaceutical Research, 2010
- Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsNature Materials, 2009
- Porous silicon in drug delivery devices and materials☆Advanced Drug Delivery Reviews, 2008
- Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomasBritish Journal of Cancer, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBritish Journal of Cancer, 2003